Patent Assignment
Reel/Frame 033264/0140
Assignment of Assignor's Interest
Recorded: 2014-07-08
Pages: 4
Assignor
ALKERMES PHARMA IRELAND LIMITED
Executed: 2014-04-23
Assignee
OTSUKA PHARMACEUTICAL CO., LTD.
SHINAGAWA GRAND CENTRAL TOWER, 2-16-4 KONAN, MINATO-KU, TOKYO, 108-8242, JAPAN
Covered Property
(1)
Nanoparticulate aripiprazole formulations
Application:
11/520,058 →
Publication:
US 2007/0148100
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Change of Name
Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029104/0071 →
Asset Transfer Agreement
Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029108/0426 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Termination and Release of Security Interest in Patents (First Lien)
Feb 4, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 032161/0475 →
Release of Patent Security Agreement (First Lien)
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →